TrialPloS one2016

Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.

William B Stubblefield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.